DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS), Cerebral Infarction
MANUFACTURER: Mitsubishi Tanabe Pharma Co., Ltd.
USAGE: Intravenous
MEDICINE APPROVED BY:
Food and Drug Administration (FDA)
Health Canada
Pharmaceuticals and Medical Devices Agency (PMDA)
Radicut, also known as Edaravone, is a prescription medication used in the treatment of Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. This medication has garnered attention for its potential to slow down the progression of ALS, offering new hope to individuals living with this devastating condition.
